Eamonn Hobbs
Founder presso ImmunSYS, Inc.
Profilo
Eamonn P.
Hobbs has founded multiple companies.
He founded AngioDynamics, Inc. in 1988 and served as Vice Chairman.
In 1983, he founded Hobbs Medical, Inc. and held the titles of Chairman, President, and Chief Executive Officer.
In 2013, he founded Hobbs Medical Ventures, LLC and served as President.
In 2018, he founded ImmunSYS, Inc. and currently serves as a Director.
Mr. Hobbs currently holds several positions.
Since 2020, he has been the President, Chief Executive Officer, and Director of Syncromune, Inc. Since 2014, he has been the Chairman of Marvao Medical Devices Ltd.
Since 2012, he has been a Director at Harmonic Medical, Inc.Mr. Hobbs has held several former positions.
From 2009 to 2016, he was the President, Chief Executive Officer, and Director of Antares Pharma, Inc. From 2008 to 2013, he held the same positions at Delcath Systems, Inc. From 2016 to 2017, he was the President and Chief Executive Officer of Digital Cognition Technologies, Inc. He also served as the Chairman of Morris Innovative Research, Inc. and as an Independent Director at OraSure Technologies, Inc. from 2016 to 2022.
Additionally, he held various director positions at Cappella, Inc., The Medical Device Manufacturers Association, Namico, Inc., North American Instrument Corp., Society of Interventional Radiology, Sentinelle Medical ULC, SIR Foundation, and E-Z-EM, Inc. He was also a Product Development Engineer at Cook, Inc. and a Member of the Governors Board at Glens Falls Hospital, Inc.Mr. Hobbs obtained his undergraduate degree from the University of Massachusetts in 1980.
Posizioni attive di Eamonn Hobbs
| Società | Posizione | Inizio |
|---|---|---|
Marvao Medical Devices Ltd.
 Marvao Medical Devices Ltd. Medical SpecialtiesHealth Technology Marvao Medical Devices Ltd. designs develop and markets novel medical devices. It provides products include NexSite 9Fr dual and NexSitetm 8Fr single lumen central venous catheters, as well as NexSite hemodialysis and drainage catheters. The company was founded by Christopher Davey and Mark A. Saab in 2006 and is headquartered in Dublin, Ireland. | Chairman | 03/03/2014 |
Harmonic Medical, Inc.
 Harmonic Medical, Inc. Medical SpecialtiesHealth Technology Harmonic Medical, Inc. develops non-invasive surgery treatment for uterine fibroids. It also treats broad range of cancer treatment such as bone metastases, metastic liver cancer, hepatocellular carcinoma, thyroid cancer, pancreatic cancer, and kidney cancer. The company is headquartered in Toronto, Canada. | Director/Board Member | 01/01/2012 |
ImmunSYS, Inc.
 ImmunSYS, Inc. Pharmaceuticals: MajorHealth Technology ImmunSYS, Inc. is a clinical stage biopharmaceutical company focused on the development of cancer immunotherapy products. The company was founded by Eamonn P. Hobbs and Charles J. Link Jr. in March 2018 and is headquartered in Fort Lauderdale, FL. | Founder | 01/03/2018 |
Syncromune, Inc.
 Syncromune, Inc. Pharmaceuticals: MajorHealth Technology Syncromune, Inc. is a clinical-stage biopharmaceutical company that is dedicated to developing an in situ platform technology optimized for metastatic solid tumor cancers. The company is based in Fort Lauderdale, FL. The company is currently developing Sync-T™, a novel combination drug/device treatment platform that aims to achieve high response rates with potentially curative efficacy. The therapy is designed to synchronize in situ neoantigen T cell education and immunostimulation via intratumoral/locoregional infusion, with the goal of enabling the immune system to recognize and attack cancer throughout the body. The first two candidates, SV-101 and SV-102, are currently in investigator-initiated phase 1 trials. Link. The company was founded in 2020 by Charles J. Eamonn P. Hobbs has been the CEO of the company since 2020. | Chief Executive Officer | 01/12/2020 |
Precedenti posizioni note di Eamonn Hobbs
| Società | Posizione | Fine |
|---|---|---|
| ORASURE TECHNOLOGIES, INC. | Director/Board Member | 08/11/2022 |
Hobbs Medical Ventures, LLC
 Hobbs Medical Ventures, LLC Miscellaneous Commercial ServicesCommercial Services Hobbs Medical Ventures, LLC provides consulting services for the pharmaceutical industry. The private company is based in New York, NY. The company was founded by Eamonn P. Hobbs. | Founder | 24/08/2022 |
Digital Cognition Technologies, Inc.
 Digital Cognition Technologies, Inc. Medical SpecialtiesHealth Technology Digital Cognition Technologies, Inc. develops detect presymptomatic cognitive impairment and aid in tracking cognitive devices. The company was founded by Randall S. Davis, Dana L. Penney and Phil A. Cooper in 2015 and is headquartered in Waltham, MA. | Chief Executive Officer | 01/06/2017 |
| ANTARES PHARMA, INC. | Chief Executive Officer | 24/01/2016 |
| DELCATH SYSTEMS, INC. | Chief Executive Officer | 10/09/2013 |
Formazione di Eamonn Hobbs
| University of Massachusetts | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| ORASURE TECHNOLOGIES, INC. | Health Technology |
| DELCATH SYSTEMS, INC. | Health Technology |
| ANGIODYNAMICS, INC. | Health Technology |
| Aziende private | 19 |
|---|---|
E-Z-EM, Inc.
 E-Z-EM, Inc. Medical SpecialtiesHealth Technology E-Z-EM, Inc. develops, manufactures and markets diagnostic imaging products. The firm's products are used for computed tomography and magnetic resonance imaging, colorectal cancer screening, evaluation of swallowing disorders and testing for other diseases, and disorders of the gastrointestinal system. The company was founded in 1961 and is headquartered in Lake Success, NY. | Health Technology |
Antares Pharma, Inc.
 Antares Pharma, Inc. Pharmaceuticals: MajorHealth Technology Antares Pharma, Inc. is a specialty pharmaceutical company, which engages in the development and commercialization of pharmaceutical products and technologies in targeted therapeutic areas. Its products include XYOSTED injection, OTREXUP injection for subcutaneous use, and Sumatriptan injection. The company was founded in February 1979 and is headquartered in Ewing, NJ. | Health Technology |
Morris Innovative Research, Inc.
 Morris Innovative Research, Inc. Medical SpecialtiesHealth Technology Morris Innovative Research, Inc. manufactures medical devices. It develops a medical device for safer access to the femoral artery for certain heart procedures. The company was founded by Andrew James DeNardo and Edward Joseph Morris in 2002 and is headquartered in Bloomington, IN. | Health Technology |
Cappella, Inc.
 Cappella, Inc. Pharmaceuticals: MajorHealth Technology Cappella, Inc. operates as a medical device company, which develops novel solutions for the treatment of complex coronary artery disease (CAD) and specifically bifurcation vascular disease. The company was founded by Antonio Columbo and Ascher Shmulewitz in 2004 and is headquartered in Boston, MA. | Health Technology |
Cook, Inc.
 Cook, Inc. Medical DistributorsDistribution Services Cook, Inc. develops healthcare devices. The company integrates minimally invasive medical device design, biopharma, gene and cell therapy, and biotech to enhance patient safety as well as improve clinical outcomes in the fields of aortic intervention, interventional cardiology, critical care medicine, gastroenterology, radiology, peripheral vascular, bone access & oncology, surgery and soft tissue repair, urology, and assisted reproductive technology, gynecology as well as high-risk obstetrics. The company is located in Bloomington, IN. | Distribution Services |
The Medical Device Manufacturers Association
 The Medical Device Manufacturers Association Miscellaneous Commercial ServicesCommercial Services The Medical Device Manufacturers Association operates as a trade association. The private company is based in Washington. The American company was founded by Thomas C. Thompson. | Commercial Services |
Glens Falls Hospital, Inc.
 Glens Falls Hospital, Inc. Hospital/Nursing ManagementHealth Services Glens Falls Hospital, Inc. provides health care services. It offers hospital, surgical and community services, and outpatient care centers. The company was founded in 1897 and is headquartered in Glens Falls, NY. | Health Services |
| Namico, Inc. | |
| North American Instrument Corp. | Miscellaneous |
Society of Interventional Radiology
 Society of Interventional Radiology Miscellaneous Commercial ServicesCommercial Services The Society of Interventional Radiology is a national organization based in Fairfax, VA, consisting of physicians, scientists, and allied health professionals. The company is dedicated to improving public health through disease management and minimally invasive, image-guided therapeutic interventions. | Commercial Services |
| Hobbs Medical, Inc. | |
Sentinelle Medical ULC
 Sentinelle Medical ULC Packaged SoftwareTechnology Services Sentinelle technology is developed by clinicians for clinicians and has evolved over ten years and more than 10000 patient trials. Its products come out of diagnostic imaging research initially conducted at Sunnybrook Health Sciences Centre and the University of Toronto Medical Biophysics department, and continuing over the past three years at Sentinelle. Its ongoing collaboration with academic institutions ensures Sentinelle technology is at the leading edge of the field of breast MRI imaging advances. Sentinelle develops products for General Electric Healthcare, Siemens Medical Solutions and Toshiba Medical Systems. Sentinelle Medical Inc., established in 2004, is a private company based in Toronto, Canada. | Technology Services |
| SIR Foundation | |
Marvao Medical Devices Ltd.
Marvao Medical Devices Ltd. Medical SpecialtiesHealth Technology Marvao Medical Devices Ltd. designs develop and markets novel medical devices. It provides products include NexSite 9Fr dual and NexSitetm 8Fr single lumen central venous catheters, as well as NexSite hemodialysis and drainage catheters. The company was founded by Christopher Davey and Mark A. Saab in 2006 and is headquartered in Dublin, Ireland. | Health Technology |
Harmonic Medical, Inc.
Harmonic Medical, Inc. Medical SpecialtiesHealth Technology Harmonic Medical, Inc. develops non-invasive surgery treatment for uterine fibroids. It also treats broad range of cancer treatment such as bone metastases, metastic liver cancer, hepatocellular carcinoma, thyroid cancer, pancreatic cancer, and kidney cancer. The company is headquartered in Toronto, Canada. | Health Technology |
Digital Cognition Technologies, Inc.
Digital Cognition Technologies, Inc. Medical SpecialtiesHealth Technology Digital Cognition Technologies, Inc. develops detect presymptomatic cognitive impairment and aid in tracking cognitive devices. The company was founded by Randall S. Davis, Dana L. Penney and Phil A. Cooper in 2015 and is headquartered in Waltham, MA. | Health Technology |
Hobbs Medical Ventures, LLC
Hobbs Medical Ventures, LLC Miscellaneous Commercial ServicesCommercial Services Hobbs Medical Ventures, LLC provides consulting services for the pharmaceutical industry. The private company is based in New York, NY. The company was founded by Eamonn P. Hobbs. | Commercial Services |
ImmunSYS, Inc.
ImmunSYS, Inc. Pharmaceuticals: MajorHealth Technology ImmunSYS, Inc. is a clinical stage biopharmaceutical company focused on the development of cancer immunotherapy products. The company was founded by Eamonn P. Hobbs and Charles J. Link Jr. in March 2018 and is headquartered in Fort Lauderdale, FL. | Health Technology |
Syncromune, Inc.
Syncromune, Inc. Pharmaceuticals: MajorHealth Technology Syncromune, Inc. is a clinical-stage biopharmaceutical company that is dedicated to developing an in situ platform technology optimized for metastatic solid tumor cancers. The company is based in Fort Lauderdale, FL. The company is currently developing Sync-T™, a novel combination drug/device treatment platform that aims to achieve high response rates with potentially curative efficacy. The therapy is designed to synchronize in situ neoantigen T cell education and immunostimulation via intratumoral/locoregional infusion, with the goal of enabling the immune system to recognize and attack cancer throughout the body. The first two candidates, SV-101 and SV-102, are currently in investigator-initiated phase 1 trials. Link. The company was founded in 2020 by Charles J. Eamonn P. Hobbs has been the CEO of the company since 2020. | Health Technology |
- Borsa valori
- Insiders
- Eamonn Hobbs
